Wolfgang Wienand is a business executive. He is the Chief Executive Officer of Lonza Group. Lonza Group is one of the companies that helps other companies make medicines. They work with companies that make biopharmaceutical, pharmaceutical and biotechnology products.
Wolfgang Wienand became the Chief Executive Officer of Lonza Group in July 2024. Since then Wolfgang Wienand has been helping Lonza Group change the way it works. The goal of this change is to make Lonza Group stronger, around the world and to focus on what it does. Wolfgang Wienand and Lonza Group are working hard to make this happen.
A Strategic Appointment
Lonza picked Wienand to be their boss in April 2024. They wanted him to take the place of Albert M. Baehny, who was in charge for a while after some big changes happened at Lonza. Wienand used to be the boss of Siegfried Holding AG, which’s another big company in Switzerland that does the same kind of work, as Lonza. He left Siegfried Holding AG. Started working at Lonza in the summer of 2024. Wienand is now the CEO of Lonza.
Wienand became a CEO after working in the industry for twenty years. He started working at Evonik Industries, a company in Germany that makes chemicals. Later Wienand joined Siegfried in 2010. At Siegfried Wienand had jobs like Chief Scientific Officer and Chief Strategy Officer. Then in 2019 Wienand was made the CEO of Siegfried. Wienand has a lot of experience, in the industry, which helped him become a CEO.
Vision for Lonza: ‘One Lonza’ Strategy
Lonza is doing something under Wienands leadership. The company is following what it calls the “One Lonza” plan. This plan is an idea to help the company grow and work better together.
The main goal of the “One Lonza” plan is to make the company strong by focusing on what it does. This means Lonza will work on making things and getting better at making things for other companies.
The company wants to make things simpler and get rid of things that’re not important. It wants to be really good at using technologies to make things. This way Lonza can make things and do it very well. The “One Lonza” plan is about making the company great, at contract development and manufacturing.
Lonza is making a change in their plan. They have decided to stop doing the capsules and health ingredients business. Instead Lonza will focus on the parts of their business that bring in money like making biological medicines doing complicated chemistry and working on special treatments such as cell and gene therapies, for people. This change is meant to help Lonza work better and make money in the long run because the life sciences field is changing very quickly.
Industry Impact & Future Outlook
Lonza is doing well and this is because of the plan that Wienand made. At the end of January 2026 the company said they did a job, with money in 2025. They sold a lot more and made money from what they were doing. This is what Wienand wanted to happen by making things simpler and coming up with new ideas on their own. Lonza is really following the plan that Wienand made for them.
Wienand’s leadership signifies a period of stability and focused growth for Lonza in a competitive global market, as the company seeks to consolidate its position as a trusted partner for pharmaceutical and biotechnology innovators worldwide.
